Timothy Hoops

1.1k total citations
35 papers, 645 citations indexed

About

Timothy Hoops is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Timothy Hoops has authored 35 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Timothy Hoops's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Timothy Hoops is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Timothy Hoops collaborates with scholars based in United States, Canada and Italy. Timothy Hoops's co-authors include Michael J. Rindler, Nanxin Li, Shruti Naik, John P. Lynch, Veronica Colomer, Kuldeep K. Lal, Nadia Malagolini, Franca Serafini‐Cessi, Peter G. Traber and James D. Lewis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Timothy Hoops

32 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Hoops United States 14 214 193 152 105 101 35 645
Yoko Mizuno-Horikawa Japan 10 464 2.2× 174 0.9× 38 0.3× 76 0.7× 58 0.6× 18 843
Dzung T. Le United States 11 278 1.3× 78 0.4× 56 0.4× 78 0.7× 60 0.6× 15 778
Andrew D. Westmuckett United States 14 355 1.7× 112 0.6× 52 0.3× 65 0.6× 96 1.0× 18 886
Emily B. Martin United States 14 404 1.9× 39 0.2× 63 0.4× 58 0.6× 83 0.8× 46 630
Takeshi Yokoo Japan 17 290 1.4× 170 0.9× 135 0.9× 46 0.4× 49 0.5× 74 1.0k
Francesca Gulli Italy 14 128 0.6× 72 0.4× 46 0.3× 49 0.5× 40 0.4× 53 665
Z. Mishal France 13 171 0.8× 111 0.6× 51 0.3× 106 1.0× 39 0.4× 23 765
Gefei Qing Canada 16 233 1.1× 56 0.3× 129 0.8× 171 1.6× 53 0.5× 32 649
Annette Steidler Germany 18 464 2.2× 170 0.9× 40 0.3× 146 1.4× 46 0.5× 37 819
Phillip Koeffler United States 11 277 1.3× 40 0.2× 79 0.5× 75 0.7× 70 0.7× 22 599

Countries citing papers authored by Timothy Hoops

Since Specialization
Citations

This map shows the geographic impact of Timothy Hoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Hoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Hoops more than expected).

Fields of papers citing papers by Timothy Hoops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Hoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Hoops. The network helps show where Timothy Hoops may publish in the future.

Co-authorship network of co-authors of Timothy Hoops

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Hoops. A scholar is included among the top collaborators of Timothy Hoops based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Hoops. Timothy Hoops is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagnon‐Sanschagrin, Patrick, M. Davidson, Cynthia Willey, et al.. (2024). The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study. Journal of Medical Economics. 27(1). 931–940. 1 indexed citations
2.
Gagnon‐Sanschagrin, Patrick, M. Davidson, Cynthia Willey, et al.. (2023). Su1137 SUBOPTIMAL TREATMENT IN PATIENTS WITH CROHN'S DISEASE USING BIOLOGICS. Gastroenterology. 164(6). S–541. 1 indexed citations
3.
4.
Panaccione, Remo, Christopher Gasink, Timothy Hoops, et al.. (2022). O30 Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials. Oral Presentations. A17–A17. 2 indexed citations
5.
Panaccione, Remo, Bruce E. Sands, Silvio Danese, et al.. (2022). Tu1445: EFFECT OF PHARMACOKINETICS AND IMMUNOGENICITY ON CLINICAL AND ENDOSCOPIC EFFICACY IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SEAVUE STUDY. Gastroenterology. 162(7). S–963. 1 indexed citations
6.
Peyrin‐Biroulet, Laurent, Remo Panaccione, C Gasink, et al.. (2022). P495 Perianal fistula closure in patients receiving ustekinumab: Results from the SEAVUE and STARDUST trials. Journal of Crohn s and Colitis. 16(Supplement_1). i460–i460. 7 indexed citations
7.
8.
Lewis, James D., Matthieu Allez, Peter M. Irving, et al.. (2021). S851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: PROMIS-29 in the SEAVUE Study. The American Journal of Gastroenterology. 116(1). S395–S395. 1 indexed citations
9.
Irving, Peter M., B E Sands, Timothy Hoops, et al.. (2021). OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study. Journal of Crohn s and Colitis. 15(Supplement_1). S001–S002. 18 indexed citations
10.
11.
Muser, Erik, et al.. (2018). P313 Steroid and opioid use among Crohn’s patients before and after initiation of ustekinumab. Journal of Crohn s and Colitis. 12(supplement_1). S259–S259. 1 indexed citations
12.
Feldman, Steven R., Bhaskar Srivastava, Timothy Hoops, et al.. (2018). Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis. PubMed. 17(12). 1298–1308. 6 indexed citations
13.
Sandborn, William J., et al.. (2017). Ustekinumab IV Induction Results in Crohnʼs Disease Symptom Improvement Within the First Week in Anti-TNF Refractory Patients. The American Journal of Gastroenterology. 112. S403–S403.
14.
Lynch, John P. & Timothy Hoops. (2002). The genetic pathogenesis of colorectal cancer. Hematology/Oncology Clinics of North America. 16(4). 775–810. 45 indexed citations
15.
Lewis, James D., David A. Asch, Gregory G. Ginsberg, et al.. (1999). Primary care physicians’ decisions to perform flexible sigmoidoscopy. Journal of General Internal Medicine. 14(5). 297–302. 23 indexed citations
16.
Hoops, Timothy & Peter G. Traber. (1997). MOLECULAR PATHOGENESIS OF COLORECTAL CANCER. Hematology/Oncology Clinics of North America. 11(4). 609–633. 23 indexed citations
17.
Faigel, Douglas O., Brian R. Stotland, Michael L. Kochman, et al.. (1997). Device choice and experience level in endoscopic foreign object retrieval: An in vivo study. Gastrointestinal Endoscopy. 45(6). 490–492. 58 indexed citations
18.
Serafini‐Cessi, Franca, Nadia Malagolini, Timothy Hoops, & Michael J. Rindler. (1993). Biosynthesis and Oligosaccharide Processing of Human Tamm-Horsfall Glycoprotein Permanently Expressed in HeLa Cells. Biochemical and Biophysical Research Communications. 194(2). 784–790. 48 indexed citations
19.
Serafini‐Cessi, Franca, et al.. (1993). S6.8 Oligosaccharide processing of Human Tamm-Horsfall glycoprotein permanently expressed in HeLa Cells. Glycoconjugate Journal. 10(4). 259–260. 2 indexed citations
20.
Kloppel, Thomas Μ., et al.. (1987). Uncoupling of the secretory pathways for IgA and secretory component by cholestasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 253(2). G232–G240. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Mizuno-Horikawa Breakdown of academic impact, for papers by Dzung T. Le Breakdown of academic impact, for papers by Andrew D. Westmuckett Breakdown of academic impact, for papers by Emily B. Martin Breakdown of academic impact, for papers by Takeshi Yokoo Breakdown of academic impact, for papers by Francesca Gulli Breakdown of academic impact, for papers by Z. Mishal Breakdown of academic impact, for papers by Gefei Qing Breakdown of academic impact, for papers by Annette Steidler Breakdown of academic impact, for papers by Phillip Koeffler
Rankless by CCL
2026